Latest Advances in Gene Therapy for Hemophilia in Portuguese

Latest Advances in Gene Therapy for Hemophilia in Portuguese

Latest Advances in Gene Therapy for Hemophilia in Portuguese

Listen as Margareth Ozelo, MD, PhD discusses Latest Advances in Gene Therapy for Hemophilia in Portuguese

Margareth Ozelo, MD, PhD
Margareth Ozelo, MD, PhD
Assistant Professor
Department of Internal Medicine
Director of the International Hemophilia Training Centre (IHTC)
University of Campinas (UNICAMP)
Campinas, São Paulo, Brazil

Margareth Ozelo, MD, PhD, is Assistant Professor in the Department of Internal Medicine and the Director of the International Hemophilia Training Centre (IHTC) at the University of Campinas (UNICAMP) in Campinas, São Paulo, Brazil. She received her medical degree, specialist training in hematology and transfusion medicine and PhD from Unicamp before undertaking a postdoctoral fellowship in David Lillicrap’s laboratory, at Queen’s University in Kingston, Ontario, Canada.

Professor Ozelo works closely with the Brazilian federal government in developing and improving the hemophilia and inherited coagulopathies policy in Brazil. She is also very active in developing and promoting the hemophilia care in Latin America. Under her leadership of the Hemophilia Comprehensive Care Unit at Hemocentro UNICAMP in Campinas, Brazil, the center became a WFH International Hemophilia Training Centre and has trained doctors, nurses, physiotherapists, and laboratory technologists from Brazil, and many countries especially from Latin America.

Professor Ozelo is involved with several research projects, including inherited platelet disorders, gene therapy for hemophilia, risk factors for inhibitor development, immune tolerance induction, and the and the MSK-MADE (Measuring, Analyzing, Disseminating and Educating in Brazil).

Image

Supported through educational grants from BioMarin, CSL Behring, Pfizer Inc., Roche, and Spark Therapeutics

Essential SSL